Changing Face of HPV in CIN2 in Young New Zealand Women

被引：0
|
作者：
Simcock, B. [1 ]
Innes, C. [2 ]
Sykes, P. [1 ,2 ]
Harker, D. [2 ]
Williman, J. [2 ]
Van der Griend, R. [3 ]
Fitzgerald, P. [4 ]
Dudley, N. [5 ]
Eva, L. [6 ]
Sadler, L. [6 ]
Bergzoll, C. [7 ]
Petrich, S. [8 ]
Lawton, B. [9 ]
机构：
[1] Canterbury Dist Hlth Board, Christchurch, New Zealand
[2] Univ Otago, Christchurch, New Zealand
[3] Dept Pathol, Christchurch, New Zealand
[4] Southern Community Lab, Dunedin, New Zealand
[5] Waikato Hosp, Hamilton, New Zealand
[6] Natl Womens Hosp, Auckland, New Zealand
[7] Wellington Hosp, Wellington, New Zealand
[8] Dunedin Publ Hosp, Dunedin, New Zealand
[9] Univ Otago, Womens Hlth Res Ctr, Wellington, New Zealand
来源：
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY | 2017年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [1] Why young women should be screened for cervical cancer: the distinction between CIN2 and CIN3
    Herbert, Amanda
    Holdsworth, Gillian
    Kubba, Ali
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (09) : 2256 - 2257
  • [2] HPV vaccination in women treated for CIN2/3: It's still all about prevention
    Huh, Warner K.
    Cameron, Margaret
    GYNECOLOGIC ONCOLOGY, 2013, 130 (02) : 255 - 256
  • [3] HUMAN PAPILLOMAVIRUS (HPV) TESTING FOR WOMEN TREATED FOR CIN2/3 PREDICTS RECURRENT OR RESIDUAL DISEASES
    Onuki, M.
    Matsumoto, K.
    Nakao, S.
    Sakurai, M.
    Ochi, H.
    Minaguchi, T.
    Satoh, T.
    Yoshikawa, H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 607 - 607
  • [4] Conservative management of CIN2 p16 positive lesions in women with multiple HPV infection
    Maria Teresa Bruno
    Guido Scalia
    Nazario Cassaro
    Maria Costanzo
    Sara Boemi
    BMC Infectious Diseases, 20
  • [5] Conservative management of CIN2 p16 positive lesions in women with multiple HPV infection
    Bruno, Maria Teresa
    Scalia, Guido
    Cassaro, Nazario
    Costanzo, Maria
    Boemi, Sara
    BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [6] Why young women should be screened for cervical cancer: the distinction between CIN2 and CIN3 Response
    Sasieni, Peter
    Castanon, Alejandra
    Parkin, Max D.
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (09) : 2257 - 2258
  • [7] Assessment of HPV DNA Test Value in Management Women with Cytological Findings of ASC-US, CIN1 and CIN2
    Pajtler, Marija
    Milicic-Juhas, Valerija
    Milojkovic, Miodrag
    Topolovec, Zlatko
    Curzik, Darko
    Mihaljevic, Ivan
    COLLEGIUM ANTROPOLOGICUM, 2010, 34 (01) : 81 - 86
  • [8] Does HPV genotyping help to predict the presence of CIN2/3 in women with mild abnormal Pap results?
    不详
    CANCER CYTOPATHOLOGY, 2005, 105 (05): : 376 - 377
  • [9] Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort
    Bonde, Jesper
    Bottari, Fabio
    Parvu, Valentin
    Pedersen, Helle
    Yanson, Karen
    Iacobone, Anna D.
    Kodsi, Salma
    Landoni, Fabio
    Vaughan, Laurence
    Ejegod, Ditte M.
    Sandri, Maria T.
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (04) : 1033 - 1041
  • [10] CIN2 REGRESSION FOR YOUNG PATIENTS WHO WERE CONSERVATIVELY MANAGED
    Powell, R.
    Munro, A.
    Bowen, S.
    O'Leary, P.
    Semmens, J. B.
    Codde, J.
    Williams, V.
    Spilsbury, K.
    Steel, N.
    Leung, Y.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 709 - 710
12345